Filing Details

Accession Number:
0001209191-18-060168
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-11-28 19:12:58
Reporting Period:
2018-11-26
Accepted Time:
2018-11-28 19:12:58
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1339970 Atyr Pharma Inc LIFE () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1236447 Paul Schimmel 3545 John Hopkins Court, Suite #250
San Diego CA 92121
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-11-26 147,225 $0.54 882,302 No 4 P Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See Footnote
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 40,440 Direct
Common Stock 721,814 Indirect See Footnote
Footnotes
  1. Represents weighted average price for the shares. The shares were purchased at price ranging from $0.5404 to $0.5422 per share. The reporting person will provide to the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price.
  2. These shares are owned directly by Paul Schimmel Prototype PSP, Paul Schimmel Trustee, FBO Paul Schimmel. The Reporting Person is the sole owner of the Paul Schimmel Prototype PSP, Paul Schimmel Trustee, FBO Paul Schimmel.
  3. There shares are owned directly by Schimmel Revocable Trust U/A Dtd 9/6/2000. The Reporting Person and his spouse are trustees of the Schimmel Revocable Trust U/A Dtd 9/6/2000.